Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

by Victoria Atkinson, Kelly-Anne Masterman, Ingrid M Leal-Rojas, Frances E Pearson, Kristen J Radford, Yoke Seng Lee, Liam J O'Brien, Carina M Walpole, Andrew Barbour
Published 2021-03-01